Siren, L.L.C. Gossamer Bio, Inc. Transaction History
Siren, L.L.C.
- $2 Trillion
- Q3 2024
A detailed history of Siren, L.L.C. transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Siren, L.L.C. holds 207,000 shares of GOSS stock, worth $169,740. This represents 0.01% of its overall portfolio holdings.
Number of Shares
207,000Holding current value
$169,740% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding GOSS
# of Institutions
107Shares Held
175MCall Options Held
474KPut Options Held
543K-
Nea Management Company, LLC Timonium, MD18.1MShares$14.8 Million1.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$9.64 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY9.19MShares$7.53 Million1.91% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$6.61 Million4.79% of portfolio
-
Palo Alto Investors LP Palo Alto, CA6.28MShares$5.15 Million0.72% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $77M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...